Department of Radiation Oncology, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, 270 Dongan Road, Xuhui, Shanghai, 200032, China.
Radiat Oncol. 2018 Dec 27;13(1):255. doi: 10.1186/s13014-018-1199-3.
Elective use of radiation therapy to treat regionally involved lymph nodes (LNs) after radical surgery for esophageal squamous cell carcinoma (ESCC) is controversial. We studied metastasis patterns through a pooled analysis of published results to guide post-operative radiotherapy (PORT) target designation.
We searched the MEDLINE database for literature published from May 1977 to March 2018, and found 14 relevant original studies that included 2738 patients with thoracic ESCC. We calculated probabilities of recurrence and metastasis in local (including anastomoses and tumor bed), LNs and distal areas.
Recurrence rates were 1.88% for local, 13.18% for distal, and 22.16% for LNs. Within LNs, recurrence rates were cervical/supraclavicular: 37.69%, upper mediastinal: 44.30%, middle mediastinal: 21.81%, lower mediastinal: 2.57%, abdominal paraaortic: 25% and upper abdominal: 9.56%. Whereas cervical/supraclavicular and upper mediastinal LNs had the highest recurrence rates, abdominal LNs also had high recurrence rates in patients with lower thoracic ESCC.
PORT volume should include the cervical/supraclavicular and upper mediastinal LNs for all thoracic ESCC, and abdominal paraaortic LNs for lower thoracic ESCC. Anastomoses and tumor beds should not be included in the PORT volume if they are not adjacent to the PORT-LN regions. Upper abdominal LNs might not necessarily be included in the PORT volume for thoracic ESCC.
根治性手术后,选择性使用放疗治疗局部淋巴结(LN)转移的食管鳞癌(ESCC)存在争议。我们通过对已发表结果的汇总分析来研究转移模式,以指导术后放疗(PORT)靶区的确定。
我们在 MEDLINE 数据库中搜索了 1977 年 5 月至 2018 年 3 月发表的文献,发现了 14 项包含 2738 例胸段 ESCC 患者的相关原始研究。我们计算了局部(包括吻合口和肿瘤床)、LN 和远端区域的复发和转移概率。
局部复发率为 1.88%,远端复发率为 13.18%,LN 复发率为 22.16%。在 LN 内,颈/锁骨上和上纵隔的复发率分别为 37.69%、44.30%、21.81%、2.57%、腹主动脉旁 25%和上腹部 9.56%。尽管颈/锁骨上和上纵隔的 LN 复发率最高,但在胸下段 ESCC 患者中,腹侧 LN 的复发率也很高。
对于所有胸段 ESCC,PORT 体积应包括颈/锁骨上和上纵隔 LN,对于胸下段 ESCC,应包括腹主动脉旁 LN。如果 PORT-LN 区域不相邻,吻合口和肿瘤床不应包括在 PORT 体积内。对于胸段 ESCC,不一定包括上腹部 LN。